bad reaction to semaglutide Ozempic and GLP-1 Drugs: Risk of Severe Side Effects Woman shares journey of weight

But they may also be viewed or treated differently by their partners and others, especially if theres substantial weight loss

People with certain medical conditions should not take Wegovy for weight loss, including those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2)

and WEGOVY Biotherapeutic GLP-1 receptor agonist Semaglutide LAI is a once-weekly subcutaneous GLP-1 receptor agonist (94% homologous to human GLP-1) indicated for glycemic control in type 2 diabetes

I am pleased with the results

It usually takes several months to see the full effect, as you start on a low dose, which is titrated up monthly